Contact Us News & Media Font Size Home About Us Products Research Responsibility Investor Relations News & Media Careers RON LLOYD Core Strengths Executive Team Executive Committee Mark Trudeau Mark Casey Meredith Fischer Matthew Harbaugh Ron Lloyd Hugh O'Neill Gary Phillips, M.D. Steven Romano, M.D. Dr. Frank Scholz Karen Sheehy Ian Watkins Select Senior Leaders Coleman Lannum Tunde Otulana, M.D. Dagmar Rosa-Björkeson Kathleen Schaefer Board of Directors 150th Anniversary Our Story Inclusion and Diversity Partnering News & Media Blog Patient Stories Careers at Mallinckrodt Community Outreach Investor Relations Ron Lloyd Executive Vice President and President, Hospital Therapies Ron Lloyd is executive vice president and president of hospital therapies at Mallinckrodt Pharmaceuticals. He has executive responsibility and directly manages all commercialization efforts for the company's hospital portfolio within its Specialty Brands segment. Mr. Lloyd is a member of Mallinckrodt’s executive committee. Mr. Lloyd has nearly 30 years of experience in the U.S. and internationally in sales and marketing, new product planning, business development, strategic planning, and general management in the pharmaceutical industry. Before joining Mallinckrodt, Mr. Lloyd was president of immunology, leading commercial operations in North America and Europe for Baxalta, and previously held various commercial leadership positions within the bioscience business at Baxter Healthcare. He also served in a number of commercial and business development capacities at Abbott Laboratories. Mr. Lloyd holds a bachelor's degree in management science from Westminster College and a master's degree in Industrial Administration from Carnegie Mellon University. Back Building On Our Heritage Nearly 150 years of quality, integrity and service. Learn More Our Culture From philanthropic efforts to advocacy initiatives, we are living our hallmarks throughout our communities. Learn How Resources for: Career Seekers Investors Suppliers About Mallinckrodt: About Us Home Investor Relations News & Media Products Research Responsibility Other Links: Blog Calif. Supply Chain Disclosure Contact Us Patents Privacy Policy Safety Data Sheets Terms of Use UK Modern Slavery Act Disclosure Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company. © 2018 Mallinckrodt. Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland. Blog LinkedIn + Cookies Policy Mallinckrodt uses cookies to improve and analyze site functionality. Some aspects of the site may not function properly without cookies enabled. To learn more about how we use cookies and how you can change your cookies setting, please read our Privacy Policy. By continuing to browse the site, you are agreeing to accept our use of cookies. I Agree ›